Ocugen director exercises options for 194,134 shares
Ocugen, Inc. director Zhang Junge exercised stock options to acquire additional common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Ocugen, Inc. director Zhang Junge exercised stock options to acquire additional common shares. On April 1, 2026, he exercised options covering 194,134 shares of common stock at exercise prices of $0.51, $0.46, and $1.42 per share. Following these exercises, he directly owns 1,359,316 common shares. The options had previously vested and become exercisable between January 2020 and June 2025.
Insider Trade Summary
194,134 shares exercised/converted
Exercise
6 txns
Insider
Zhang Junge
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (right to buy) | 15,000 | $0.00 | $0.00 |
| Exercise | Option (right to buy) | 112,205 | $0.00 | $0.00 |
| Exercise | Option (right to buy) | 66,929 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,000 | $0.51 | $8K |
| Exercise | Common Stock | 112,205 | $0.46 | $52K |
| Exercise | Common Stock | 66,929 | $1.42 | $95K |
Holdings After Transaction:
Option (right to buy) — 0 contracts (Direct);
Common Stock — 1,359,316 shares (Direct)
Footnotes (3)
- F1. The option, initially representing a right to purchase 54,000 shares, vested and became exercisable in equal installments over three years commencing on January 2, 2020.
- F2. The option, representing a right to purchase 112,205 shares, vested and became exercisable on June 9, 2024.
- F3. The option, representing a right to purchase 66,929 shares, vested and became exercisable on June 28, 2025.
Key Figures
Options exercised: 194,134 shares
Exercise price 1: $0.51/share
Exercise price 2: $0.46/share
+5 more
8 metrics
Options exercised
194,134 shares
Total underlying common shares from option exercises on April 1, 2026
Exercise price 1
$0.51/share
Option for 15,000 shares of common stock
Exercise price 2
$0.46/share
Option for 112,205 shares of common stock
Exercise price 3
$1.42/share
Option for 66,929 shares of common stock
Direct holdings after transactions
1,359,316 shares
Common stock directly owned after exercises
Option expiration 1
January 2, 2030
Expiration date for option initially for 54,000 shares
Option expiration 2
June 9, 2033
Expiration date for 112,205-share option grant
Option expiration 3
June 28, 2034
Expiration date for 66,929-share option grant
Key Terms
Option (right to buy), Exercise or conversion of derivative security, derivative exercise/conversion, vested and became exercisable, +1 more
5 terms
Option (right to buy) financial
"security_title: "Option (right to buy)""
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion""
vested and became exercisable financial
"footnote: "vested and became exercisable on June 9, 2024""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ocugen (OCGN) director Zhang Junge report in this Form 4?
Zhang Junge reported exercising stock options to acquire 194,134 Ocugen common shares. These option exercises converted previously granted, vested options into directly held stock, increasing his direct ownership stake to 1,359,316 common shares as of the reported date.
At what prices were the Ocugen (OCGN) options exercised by Zhang Junge?
The options were exercised at strike prices of $0.51, $0.46, and $1.42 per share. Each price corresponds to a different option grant, all of which had vested before the April 1, 2026 exercise date noted in the Form 4.
What is Zhang Junge’s Ocugen (OCGN) ownership after these transactions?
After the reported option exercises, Zhang Junge directly owns 1,359,316 Ocugen common shares. This figure reflects his position following the conversion of 194,134 option rights into common stock on April 1, 2026, as shown in the filing.
What do the vesting footnotes in the Ocugen (OCGN) Form 4 explain?
The footnotes describe when each option grant vested and became exercisable. One grant vested in three annual installments starting January 2, 2020, while the other grants became fully exercisable on June 9, 2024 and June 28, 2025, respectively.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates